NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Update - March 11

Indices Trading in the Red The Sensex and Nifty were trading in the red as mixed signals over the US-Israel war on Iran left investors uncertain about its impact on inflation and growth. At 10:37 am, the Sensex was down 606.95 points or 0.78% at 77,599.03, and the Nifty was down 171.45 points or 0.71% at 24,090.15.

Trading Activity Out of 2,533 shares traded, 2,373 shares advanced, 1,123 shares declined, and 159 shares were unchanged. Foreign institutional investors (FIIs) have continued to remain net sellers of Rs 4,673 crore, while domestic institutional investors (DIIs) did net buying of over Rs 6,333 crore on March 10.

Sectoral Performance Auto, financials, IT, and FMCG stocks led the decline with sectoral indices trading 0.4%-0.6% lower. Financial services companies Kotak Mahindra Bank, SBI Life Insurance Co., Bajaj Finserv, and Bajaj Finance were the worst hit in the Nifty 50 index, down around 1% each. Bharti Airtel and Tata Consumer Products were also down around 1% each.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Middle East Crisis The Middle East crisis has kept investors on edge, as the United States and Israel launched what some described as the war's heaviest strikes on Iran. US President Donald Trump said on Monday that the conflict could be "over soon", leaving investors uncertain about its impact on inflation and growth.

Investor Takeaway

Investors should be cautious of the ongoing market decline and potential impact of global events on Indian equities.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.